Skip to main content
Support

In New Life, Old Bottles: Regulating First-Generation Products of Synthetic Biology, Michael Rodemeyer examines the benefits and drawbacks of using the existing U.S. regulatory framework for biotechnology to cover the new products and processes enabled by synthetic biology. The safety of early applications of synthetic biology may be adequately addressed by the existing regulatory framework for biotechnology, especially in contained laboratories and manufacturing facilities, according to the report. But further advances in this emerging field are likely to create significant challenges for U.S. government oversight.

About the Author

Michael Rodemeyer

Read More

Science and Technology Innovation Program

The Science and Technology Innovation Program (STIP) brings foresight to the frontier. Our experts explore emerging technologies through vital conversations, making science policy accessible to everyone.  Read more

Tagged